SCM Pharma’s clinical development and manufacturing facility in Prudhoe, UK, has been approved by the FDA. The inspection was triggered by the preparation for the commercial launch of BTG’s Varithena (polidocanol injectable foam), following clinical development consultation for the product.    The FDA has approved BTG’s varicose veins treatment (previously known as Varisolve PEM), which uses an injectable, pharmaceutical-grade foam to dissolve the veins as an alternative to surgery. SCM’s Prudho...